Henry Schein, Inc.
HSIC
Rang in Aktien
#2159
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive... Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Aktienkurs
$84.80
Marktkapitalisierung
$9.45B
Veränderung (1 Tag)
0.99%
Veränderung (1 Jahr)
32.65%
Land
US
Handel Henry Schein, Inc. (HSIC)
Kategorie
Healthcare
Gewinn für Henry Schein, Inc. (HSIC)
Gewinn im Jun 2026 TTM: $558.00M
Laut den aktuellen Finanzberichten von Henry Schein, Inc. betragen die aktuellen Gewinne des Unternehmens $558.00M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $556.00M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $736.00M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Henry Schein, Inc. von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $558.00M | 6.08% |
| 2024 | $526.00M | -5.40% |
| 2023 | $556.00M | -24.46% |
| 2022 | $736.00M | -13.47% |
| 2021 | $850.56M | 66.05% |
| 2020 | $512.24M | -26.64% |
| 2019 | $698.21M | 25.16% |
| 2018 | $557.87M | -32.12% |
| 2017 | $821.80M | 6.13% |
| 2016 | $774.35M | 5.38% |
| 2015 | $734.82M | 1.91% |
| 2014 | $721.05M | 6.84% |
| 2013 | $674.89M | 10.41% |
| 2012 | $611.25M | 4.51% |
| 2011 | $584.87M | 14.19% |
| 2010 | $512.20M | 11.84% |
| 2009 | $457.96M | 14.35% |
| 2008 | $400.49M | 4.79% |
| 2007 | $382.17M | 29.21% |
| 2006 | $295.77M | 19.53% |
| 2005 | $247.43M | 24.57% |
| 2004 | $198.63M | -12.02% |
| 2003 | $225.78M | 19.78% |
| 2002 | $188.50M | 34.30% |
| 2001 | $140.35M | 51.08% |
| 2000 | $92.90M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $6.46B | 1,057.35% |
US
|
|
| - | - |
US
|
|
| $2.17B | 289.61% |
US
|
|
| - | - |
US
|
|
| $708.86M | 27.04% |
AU
|
